(4-((3-Bromophenyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

3-Iodo-1H-indazole, 95.0%, 1g

1H,1H,5H-Octafluoropentyl-1,1,2,2-tetrafluoroethyl ether, 97.0%, 1g

2,4,5-Trichlorobenzenesulfonyl chloride, 98.0%, 50g

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(4-CYANOPHENYL)BUTANOIC ACID, 95%, 5g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, no certificados, 0,001 g, 620 g, BCE623i-1S (W)

2-Oxocyclohexanecarboxylic acid sodium salt, 97.0%, 250mg

Magnesium Phenoxyacetate Dihydrate>98.0%(T)25g

2-(Benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxaldehyde>98.0%(GC)5g

4-((4-Isopropylbenzyl)amino)phenol, 95%, 1g

(R)-�-(3-Bromophenyl)alaninol, 97.0%, 1g

4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine, 95.0%, 250mg